# Impact of coronary revascularization on clinical outcomes of postacute myocardial infarction patients with left ventricular thrombus

**Authors:** Andre Wen–Jie Seah, Aloysius Sheng–Ting Leow, Fang–Qin Goh, Benjamin Yong–Qiang Tan, Leonard Leong–Litt Yeo, William K.F. Kong, Kian–Keong Poh, James W.L. Yip, Raymond Ching–Chiew Wong, Ping Chai, Tiong–Cheng Yeo, Mark Yan–Yee Chan, Xin Zhou, Gregory Y.H. Lip, Ching–Hui Sia

PMC · DOI: 10.1016/j.rpth.2025.102897 · Research and Practice in Thrombosis and Haemostasis · 2025-05-21

## TL;DR

This study found that not undergoing coronary revascularization after a heart attack with left ventricular thrombus is linked to higher mortality, but not to the resolution of the thrombus.

## Contribution

The study provides new evidence on the association between revascularization and outcomes in post-AMI patients with left ventricular thrombus.

## Key findings

- Lack of revascularization was associated with higher mortality in post-AMI LVT patients.
- Revascularization was not significantly associated with LVT resolution.
- Optimizing medical therapy is emphasized as a key treatment goal.

## Abstract

The incidence of left ventricular thrombus (LVT), a significant complication postacute myocardial infarction (AMI), has seen a decline in the percutaneous coronary intervention era. Patients may not undergo coronary revascularization due to medical contraindications or patient preference.

This study compared post-AMI LVT patients treated with or without revascularization.

This was a retrospective study of 263 consecutive post-AMI patients diagnosed with LVT from November 2012 to January 2021, retrieved from an echocardiography database. Patients were stratified by their revascularization status.

Mean (SD) follow-up duration was 2.1 ± 2.1 years. Most post-AMI LVT patients underwent revascularization via percutaneous coronary intervention (71.5%; n = 188). Unrevascularized patients (24.0%; n = 63) were older (P < .001), more often female (P < .001), more comorbid, less likely to have anterior AMI (P < .001), or treated with anticoagulation (P < .001). In multivariable analysis, at least anticoagulation + P2Y12 inhibitor (adjusted hazard ratio [aHR], 1.84; 95% CI, 1.14-2.96; P = .01), but not revascularization (aHR, 1.25; 95% CI, 0.74-2.13; P = .40), was associated with LVT resolution. Both absence of revascularization (aHR, 2.30; 95% CI, 1.09-4.85; P = .03) and LVT resolution (aHR, 6.06; 95% CI, 2.99-12.3; P < .001) were associated with higher mortality after adjusting for age, sex, anemia, anterior AMI, and ejection fraction.

Lack of revascularization in post-AMI LVT patients was associated with higher mortality but not LVT resolution. Optimizing medical therapy remains a key treatment goal.

•Left ventricular thrombus (LVT) formation is a significant complication in postacute myocardial infarction (AMI) patients. The impact of revascularization in such patients is unclear.•This was a retrospective study from a single center of 263 consecutive post-AMI patients with LVT from 2012 to 2021 in an echocardiography database, stratified by revascularization status.•Lack of revascularization in post-AMI LVT patients was associated with higher mortality but not LVT resolution.•Optimizing medical therapy remains a key treatment goal.

Left ventricular thrombus (LVT) formation is a significant complication in postacute myocardial infarction (AMI) patients. The impact of revascularization in such patients is unclear.

This was a retrospective study from a single center of 263 consecutive post-AMI patients with LVT from 2012 to 2021 in an echocardiography database, stratified by revascularization status.

Lack of revascularization in post-AMI LVT patients was associated with higher mortality but not LVT resolution.

Optimizing medical therapy remains a key treatment goal.

## Linked entities

- **Diseases:** myocardial infarction (MONDO:0005068)

## Full-text entities

- **Diseases:** myocardial infarction (MESH:D009203), AMI (MESH:D000081011), anemia (MESH:D000740), LVT (MESH:D013927)
- **Chemicals:** P2Y12 inhibitor (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12210294/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12210294/full.md

## References

38 references — full list in the complete paper: https://tomesphere.com/paper/PMC12210294/full.md

---
Source: https://tomesphere.com/paper/PMC12210294